Next Article in Journal
S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer
Previous Article in Journal
The Potential of Epigallocatechin-3-gallate (EGCG) as Complementary Medicine for the Treatment of Inflammatory Bowel Disease
 
 
Review

Article Versions Notes

Pharmaceuticals 2023, 16(5), 747; https://doi.org/10.3390/ph16050747
Action Date Notes Link
article pdf uploaded. 14 May 2023 11:29 CEST Version of Record https://www.mdpi.com/1424-8247/16/5/747/pdf-vor
article pdf uploaded. 15 May 2023 04:57 CEST Updated version of record https://www.mdpi.com/1424-8247/16/5/747/pdf-vor
article xml uploaded. 15 May 2023 09:17 CEST Original file https://www.mdpi.com/1424-8247/16/5/747/xml
article pdf uploaded. 15 May 2023 09:17 CEST Updated version of record https://www.mdpi.com/1424-8247/16/5/747/pdf
article html file updated 15 May 2023 09:19 CEST Original file https://www.mdpi.com/1424-8247/16/5/747/html
Back to TopTop